Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$0.69 - $0.9 $13,799 - $18,000
-20,000 Closed
0 $0
Q3 2020

Jan 27, 2023

BUY
$0.72 - $1.04 $14,400 - $20,800
20,000 New
20,000 $15,000
Q3 2020

Nov 16, 2020

SELL
$0.72 - $1.04 $11,736 - $16,952
-16,300 Reduced 44.9%
20,000 $15,000
Q2 2020

Aug 17, 2020

BUY
$0.63 - $1.1 $22,869 - $39,930
36,300 New
36,300 $35,000

About ENDRA Life Sciences Inc.


  • Ticker NDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 63,174,500
  • Market Cap $339M
  • Description
  • ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperat...
More about NDRA
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.